DR-01

Generic Name: DR-01

Brand Names: -

Drug Type: Biotech

Chemical Formula: -

CAS Number: -

Unique Ingredient Identifier: -

Background: DR-01 is a monoclonal antibody directed against human CD94.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

A Study of Subcutaneous DR-01 in Healthy Volunteers

Phase 1

Not yet recruiting

Conditions: Healthy Volunteer

Interventions: Drug: DR-01
Other: Placebo

First Posted Date: 2025-01-09

Last Posted Date: 2025-01-10

Lead Sponsor: Dren Bio

Target Recruit Count: 36

Registration Number: NCT06766864

Locations: 🇳🇿
Dren Investigational Site, Auckland, New Zealand

A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo

Phase 1

Recruiting

Conditions: Alopecia Areata
Vitiligo

Interventions: Drug: DR-01

First Posted Date: 2024-09-19

Last Posted Date: 2025-01-01

Lead Sponsor: Dren Bio

Target Recruit Count: 60

Registration Number: NCT06602232

Locations: 🇳🇿
Dren Investigational Site, Grafton, New Zealand

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy